aluates Reports

$ 0.0

Automative

Global Active Pharmaceutical Ingredients CDMO Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-12V10168

Global Active Pharmaceutical Ingredients CDMO Market Insights Forecast to 2028

BUY CHAPTERS

Global Active Pharmaceutical Ingredients CDMO Market Research Report 2025

Code: QYRE-Auto-12V10168

Report

June 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Cambrex

Recipharm

Corden Pharma

Samsung Biologics

Lonza

Catalent

Siegfried

Piramal Pharma Solutions

Boehringer Ingelheim

Thermo Fisher Pantheon

Active Pharmaceutical Ingredients CDMO Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Active Pharmaceutical Ingredients CDMO Market

The global market for Active Pharmaceutical Ingredients CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients CDMO.

The Active Pharmaceutical Ingredients CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Active Pharmaceutical Ingredients CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Active Pharmaceutical Ingredients CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Active Pharmaceutical Ingredients CDMO Market Report

Report Metric	Details
Report Name	Active Pharmaceutical Ingredients CDMO Market
CAGR	5%
Segment by Type	Traditional Active Pharmaceutical Ingredient (Traditional API) Highly Potent Active Pharmaceutical Ingredient (HP-API) Antibody Drug Conjugate (ADC) Others
Segment by Application	Oncology Hormonal Glaucoma Cardiovascular Diabetes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cambrex, Recipharm, Thermo Fisher Pantheon, Corden Pharma, Samsung Biologics, Lonza, Catalent, Siegfried, Piramal Pharma Solutions, Boehringer Ingelheim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Active Pharmaceutical Ingredients CDMO Market report?

Ans: The main players in the Active Pharmaceutical Ingredients CDMO Market are Cambrex, Recipharm, Thermo Fisher Pantheon, Corden Pharma, Samsung Biologics, Lonza, Catalent, Siegfried, Piramal Pharma Solutions, Boehringer Ingelheim

What are the Application segmentation covered in the Active Pharmaceutical Ingredients CDMO Market report?

Ans: The Applications covered in the Active Pharmaceutical Ingredients CDMO Market report are Oncology, Hormonal, Glaucoma, Cardiovascular, Diabetes, Others

What are the Type segmentation covered in the Active Pharmaceutical Ingredients CDMO Market report?

Ans: The Types covered in the Active Pharmaceutical Ingredients CDMO Market report are Traditional Active Pharmaceutical Ingredient (Traditional API), Highly Potent Active Pharmaceutical Ingredient (HP-API), Antibody Drug Conjugate (ADC), Others

Recommended Reports

CDMO Market Overview

API and Ingredient Markets

Biologics and Advanced CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Traditional Active Pharmaceutical Ingredient (Traditional API)

1.2.3 Highly Potent Active Pharmaceutical Ingredient (HP-API)

1.2.4 Antibody Drug Conjugate (ADC)

1.2.5 Others

1.3 Market by Application

1.3.1 Global Active Pharmaceutical Ingredients CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Hormonal

1.3.4 Glaucoma

1.3.5 Cardiovascular

1.3.6 Diabetes

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Active Pharmaceutical Ingredients CDMO Market Perspective (2020-2031)

2.2 Global Active Pharmaceutical Ingredients CDMO Growth Trends by Region

2.2.1 Global Active Pharmaceutical Ingredients CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Active Pharmaceutical Ingredients CDMO Historic Market Size by Region (2020-2025)

2.2.3 Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Region (2026-2031)

2.3 Active Pharmaceutical Ingredients CDMO Market Dynamics

2.3.1 Active Pharmaceutical Ingredients CDMO Industry Trends

2.3.2 Active Pharmaceutical Ingredients CDMO Market Drivers

2.3.3 Active Pharmaceutical Ingredients CDMO Market Challenges

2.3.4 Active Pharmaceutical Ingredients CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Active Pharmaceutical Ingredients CDMO Players by Revenue

3.1.1 Global Top Active Pharmaceutical Ingredients CDMO Players by Revenue (2020-2025)

3.1.2 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Active Pharmaceutical Ingredients CDMO Revenue

3.4 Global Active Pharmaceutical Ingredients CDMO Market Concentration Ratio

3.4.1 Global Active Pharmaceutical Ingredients CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients CDMO Revenue in 2024

3.5 Global Key Players of Active Pharmaceutical Ingredients CDMO Head office and Area Served

3.6 Global Key Players of Active Pharmaceutical Ingredients CDMO, Product and Application

3.7 Global Key Players of Active Pharmaceutical Ingredients CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Active Pharmaceutical Ingredients CDMO Breakdown Data by Type

4.1 Global Active Pharmaceutical Ingredients CDMO Historic Market Size by Type (2020-2025)

4.2 Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Type (2026-2031)

5 Active Pharmaceutical Ingredients CDMO Breakdown Data by Application

5.1 Global Active Pharmaceutical Ingredients CDMO Historic Market Size by Application (2020-2025)

5.2 Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Active Pharmaceutical Ingredients CDMO Market Size (2020-2031)

6.2 North America Active Pharmaceutical Ingredients CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025)

6.4 North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Active Pharmaceutical Ingredients CDMO Market Size (2020-2031)

7.2 Europe Active Pharmaceutical Ingredients CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025)

7.4 Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size (2020-2031)

8.2 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Active Pharmaceutical Ingredients CDMO Market Size (2020-2031)

9.2 Latin America Active Pharmaceutical Ingredients CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025)

9.4 Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size (2020-2031)

10.2 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cambrex

11.1.1 Cambrex Company Details

11.1.2 Cambrex Business Overview

11.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Introduction

11.1.4 Cambrex Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.1.5 Cambrex Recent Development

11.2 Recipharm

11.2.1 Recipharm Company Details

11.2.2 Recipharm Business Overview

11.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Introduction

11.2.4 Recipharm Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.2.5 Recipharm Recent Development

11.3 Thermo Fisher Pantheon

11.3.1 Thermo Fisher Pantheon Company Details

11.3.2 Thermo Fisher Pantheon Business Overview

11.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Introduction

11.3.4 Thermo Fisher Pantheon Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.3.5 Thermo Fisher Pantheon Recent Development

11.4 Corden Pharma

11.4.1 Corden Pharma Company Details

11.4.2 Corden Pharma Business Overview

11.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Introduction

11.4.4 Corden Pharma Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.4.5 Corden Pharma Recent Development

11.5 Samsung Biologics

11.5.1 Samsung Biologics Company Details

11.5.2 Samsung Biologics Business Overview

11.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Introduction

11.5.4 Samsung Biologics Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.5.5 Samsung Biologics Recent Development

11.6 Lonza

11.6.1 Lonza Company Details

11.6.2 Lonza Business Overview

11.6.3 Lonza Active Pharmaceutical Ingredients CDMO Introduction

11.6.4 Lonza Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.6.5 Lonza Recent Development

11.7 Catalent

11.7.1 Catalent Company Details

11.7.2 Catalent Business Overview

11.7.3 Catalent Active Pharmaceutical Ingredients CDMO Introduction

11.7.4 Catalent Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.7.5 Catalent Recent Development

11.8 Siegfried

11.8.1 Siegfried Company Details

11.8.2 Siegfried Business Overview

11.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Introduction

11.8.4 Siegfried Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.8.5 Siegfried Recent Development

11.9 Piramal Pharma Solutions

11.9.1 Piramal Pharma Solutions Company Details

11.9.2 Piramal Pharma Solutions Business Overview

11.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Introduction

11.9.4 Piramal Pharma Solutions Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.9.5 Piramal Pharma Solutions Recent Development

11.10 Boehringer Ingelheim

11.10.1 Boehringer Ingelheim Company Details

11.10.2 Boehringer Ingelheim Business Overview

11.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Introduction

11.10.4 Boehringer Ingelheim Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

11.10.5 Boehringer Ingelheim Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cambrex

Recipharm

Corden Pharma

Samsung Biologics

Lonza

Catalent

Siegfried

Piramal Pharma Solutions

Boehringer Ingelheim

Thermo Fisher Pantheon

List of Tables

Table 1. Global Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Traditional Active Pharmaceutical Ingredient (Traditional API)

Table 3. Key Players of Highly Potent Active Pharmaceutical Ingredient (HP-API)

Table 4. Key Players of Antibody Drug Conjugate (ADC)

Table 5. Key Players of Others

Table 6. Global Active Pharmaceutical Ingredients CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Active Pharmaceutical Ingredients CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Active Pharmaceutical Ingredients CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Active Pharmaceutical Ingredients CDMO Market Share by Region (2020-2025)

Table 10. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Active Pharmaceutical Ingredients CDMO Market Share by Region (2026-2031)

Table 12. Active Pharmaceutical Ingredients CDMO Market Trends

Table 13. Active Pharmaceutical Ingredients CDMO Market Drivers

Table 14. Active Pharmaceutical Ingredients CDMO Market Challenges

Table 15. Active Pharmaceutical Ingredients CDMO Market Restraints

Table 16. Global Active Pharmaceutical Ingredients CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Active Pharmaceutical Ingredients CDMO Market Share by Players (2020-2025)

Table 18. Global Top Active Pharmaceutical Ingredients CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2024)

Table 19. Ranking of Global Top Active Pharmaceutical Ingredients CDMO Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Active Pharmaceutical Ingredients CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Active Pharmaceutical Ingredients CDMO, Headquarters and Area Served

Table 22. Global Key Players of Active Pharmaceutical Ingredients CDMO, Product and Application

Table 23. Global Key Players of Active Pharmaceutical Ingredients CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Active Pharmaceutical Ingredients CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type (2020-2025)

Table 27. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type (2026-2031)

Table 29. Global Active Pharmaceutical Ingredients CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application (2020-2025)

Table 31. Global Active Pharmaceutical Ingredients CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application (2026-2031)

Table 33. North America Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 48. Cambrex Company Details

Table 49. Cambrex Business Overview

Table 50. Cambrex Active Pharmaceutical Ingredients CDMO Product

Table 51. Cambrex Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 52. Cambrex Recent Development

Table 53. Recipharm Company Details

Table 54. Recipharm Business Overview

Table 55. Recipharm Active Pharmaceutical Ingredients CDMO Product

Table 56. Recipharm Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 57. Recipharm Recent Development

Table 58. Thermo Fisher Pantheon Company Details

Table 59. Thermo Fisher Pantheon Business Overview

Table 60. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product

Table 61. Thermo Fisher Pantheon Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Pantheon Recent Development

Table 63. Corden Pharma Company Details

Table 64. Corden Pharma Business Overview

Table 65. Corden Pharma Active Pharmaceutical Ingredients CDMO Product

Table 66. Corden Pharma Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 67. Corden Pharma Recent Development

Table 68. Samsung Biologics Company Details

Table 69. Samsung Biologics Business Overview

Table 70. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product

Table 71. Samsung Biologics Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 72. Samsung Biologics Recent Development

Table 73. Lonza Company Details

Table 74. Lonza Business Overview

Table 75. Lonza Active Pharmaceutical Ingredients CDMO Product

Table 76. Lonza Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 77. Lonza Recent Development

Table 78. Catalent Company Details

Table 79. Catalent Business Overview

Table 80. Catalent Active Pharmaceutical Ingredients CDMO Product

Table 81. Catalent Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 82. Catalent Recent Development

Table 83. Siegfried Company Details

Table 84. Siegfried Business Overview

Table 85. Siegfried Active Pharmaceutical Ingredients CDMO Product

Table 86. Siegfried Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 87. Siegfried Recent Development

Table 88. Piramal Pharma Solutions Company Details

Table 89. Piramal Pharma Solutions Business Overview

Table 90. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product

Table 91. Piramal Pharma Solutions Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 92. Piramal Pharma Solutions Recent Development

Table 93. Boehringer Ingelheim Company Details

Table 94. Boehringer Ingelheim Business Overview

Table 95. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product

Table 96. Boehringer Ingelheim Revenue in Active Pharmaceutical Ingredients CDMO Business (2020-2025) & (US$ Million)

Table 97. Boehringer Ingelheim Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Active Pharmaceutical Ingredients CDMO Picture

Figure 2. Global Active Pharmaceutical Ingredients CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Active Pharmaceutical Ingredients CDMO Market Share by Type: 2024 VS 2031

Figure 4. Traditional Active Pharmaceutical Ingredient (Traditional API) Features

Figure 5. Highly Potent Active Pharmaceutical Ingredient (HP-API) Features

Figure 6. Antibody Drug Conjugate (ADC) Features

Figure 7. Others Features

Figure 8. Global Active Pharmaceutical Ingredients CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Active Pharmaceutical Ingredients CDMO Market Share by Application: 2024 VS 2031

Figure 10. Oncology Case Studies

Figure 11. Hormonal Case Studies

Figure 12. Glaucoma Case Studies

Figure 13. Cardiovascular Case Studies

Figure 14. Diabetes Case Studies

Figure 15. Others Case Studies

Figure 16. Active Pharmaceutical Ingredients CDMO Report Years Considered

Figure 17. Global Active Pharmaceutical Ingredients CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Active Pharmaceutical Ingredients CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Active Pharmaceutical Ingredients CDMO Market Share by Region: 2024 VS 2031

Figure 20. Global Active Pharmaceutical Ingredients CDMO Market Share by Players in 2024

Figure 21. Global Top Active Pharmaceutical Ingredients CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredients CDMO Revenue in 2024

Figure 23. North America Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Active Pharmaceutical Ingredients CDMO Market Share by Country (2020-2031)

Figure 25. United States Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Active Pharmaceutical Ingredients CDMO Market Share by Country (2020-2031)

Figure 29. Germany Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Share by Region (2020-2031)

Figure 37. China Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Active Pharmaceutical Ingredients CDMO Market Share by Country (2020-2031)

Figure 45. Mexico Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Share by Country (2020-2031)

Figure 49. Turkey Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Active Pharmaceutical Ingredients CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Cambrex Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 53. Recipharm Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 54. Thermo Fisher Pantheon Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 55. Corden Pharma Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 56. Samsung Biologics Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 57. Lonza Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 58. Catalent Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 59. Siegfried Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 60. Piramal Pharma Solutions Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 61. Boehringer Ingelheim Revenue Growth Rate in Active Pharmaceutical Ingredients CDMO Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical CDMO Market Research Report 2025

Global Chemical CDMO Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Pharmaceutical CDMO Services Market

Global Full Service CDMO Market Research Report 2024

Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Intermediate CDMO Market Research Report 2024

Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030

Global Chemical Drug CDMO Market Research Report 2024

Global Pharmaceutical Products and CMO Market Research Report 2024

Global CMO CDMO Market Insights Forecast to 2030

Global Biopharmaceutical CDMO Market Research Report 2025

Global Innovative Drug CDMO Market Research Report 2024

Global Small Molecule Innovator CDMO Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions